US President Barack Obama last Friday announced the successful resolution of the outstanding issues with the US-Korea trade agreement, setting the stage for consideration of the agreement by Congress in the coming months.
He said: “I am very pleased that the United States and South Korea have reached agreement on a landmark trade deal that is expected to increase annual exports of American goods by up to $11 billion and support at least 70,000 American jobs. Last month in Seoul I directed our negotiators to achieve the best deal for American workers and companies, and this agreement meets that test.”
The US/Korea FTA will remove tariffs on 95% of goods traded between the two countries within five years, a move which the US International Trade Commission estimates will increase US exports to Korea by up to $11 billion a year. The initial FTA was signed in June 2007 but its ratification has been deadlocked until now due to concerns relating to automobiles, beef and agriculture.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze